SNIPR Biome

SNIPR Biome

Signal active

Organization

Contact Information

Overview

SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases. The company uses CRISPR technology that can subvert elements of the endogenous bacterial CRISPR machinery to eliminate hazardous bacteria in vivo, providing the health professionals with medicines that selectively target and kill bacteria with specific DNA sequences.

About

Industries

Biotechnology, Health Care, Biometrics

Founded

2017

Employees

11-50

Headquarters locations

Europe

Social

N/A

Profile Resume

SNIPR Biome headquartered in Europe, operates in the Biotechnology, Health Care, Biometrics sector. The company focuses on Biotechnology and has secured $3.8B in funding across 60 round(s). With a team of 11-50 employees, SNIPR Biome is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - SNIPR Biome, raised $3.2M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Christian Groendahl

Christian Groendahl

Co-Founder and CEO

Funding Rounds

Funding rounds

5

Investors

1

Lead Investors

0

Total Funding Amount

$62.6M

Details

2

SNIPR Biome has raised a total of $62.6M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2019Early Stage Venture50.0M
2017Seed3.2M

Investors

SNIPR Biome is funded by 18 investors.

Investor NameLead InvestorFunding RoundPartners
SNIPR Biome-FUNDING ROUND - SNIPR Biomeundefined
Bill & Melinda Gates Foundation-FUNDING ROUND - Bill & Melinda Gates Foundationundefined
SNIPR Biome-FUNDING ROUND - SNIPR Biome3.2M
Lundbeckfonden Emerge-FUNDING ROUND - Lundbeckfonden Emerge3.2M

Recent Activity

There is no recent news or activity for this profile.